The Non-Financial Ledger

There is a particular kind of betrayal that happens in the baby products aisle. You are exhausted. You are scared. You are holding a tiny person whose skin is so new it reacts to almost everything. You scan label after label looking for the safest possible option, and you find one that says exactly what you need to hear: powered by plants. No harsh chemicals. Hypoallergenic. Baby friendly. There is a leaf logo. There is green packaging. You buy it.

What the complaint describes is a company that knew exactly which words and images would reach a parent in that moment, and used them with precision, regardless of whether those words were true. The target demographic is stated plainly in the complaint: new and expectant mothers, families with young children, people specifically trying to protect newborns from synthetic chemical exposure. This is not a case of vague marketing language being stretched in a courtroom. The products are sold at Walmart, Target, and Amazon. They are described as safe for infants. One of the product lines is called Breast Pump Soap. Another is Pacifier Wipes.

The complaint documents that benzisothiazolinone, an ingredient present in these products and marketed to parents of newborns, is an established contact allergen. The U.S. EPA classifies it as a moderate skin sensitizer. The European Union has banned it from personal care products entirely. A baby cannot tell you something is burning. It just cries.

Sodium benzoate, also present in these products, is documented in the complaint to cause DNA damage and chromosomal aberrations. The same product line tells parents on the front of the bottle: no harsh chemicals. Ethylhexylglycerin, another ingredient, is classified in studies as a skin allergen capable of causing dermatitis. The packaging calls the product hypoallergenic.

The complaint also notes that a 2012 article in the Journal of Pediatrics flagged FDA warnings connecting xanthan gum products to illness and death in infants. Xanthan gum is listed as an ingredient. The company did not note this anywhere on its labels. It continued to market the products as safe for babies.

Every parent who bought these products based on the plant-based promise made a decision under false information. That is not an abstract legal harm. It is a violation of the trust that parents extend when they are trying, in good faith, to protect someone who cannot protect themselves.

Legal Receipts: What the Documents Say

The complaint contains direct citations from federal regulatory bodies. These are not allegations from the plaintiff’s attorneys. They are the government’s own words, applied to ingredients in Dapple Baby’s products.

“Traditionally by extraction from citrus juice, [is] no longer commercially available. It is now extracted by fermentation of a carbohydrate substance (often molasses) by citric acid bacteria, Aspergillus niger (a mold) or Candida guilliermondii (a yeast). Citric acid is recovered from the fermentation broth by a lime and sulfuric acid process in which the citric acid is first precipitated as a calcium salt and then reacidulated with sulfuric acid.”

— USDA Agricultural Marketing Service Technical Evaluation Report on Citric Acid, cited as Exhibit A in the complaint.

• This quote proves that commercial citric acid, the kind in Dapple Baby’s products, cannot be sourced from citrus fruits. The “natural” origin consumers associate with the ingredient does not exist at commercial scale.
• The process described involves industrial fermentation, sulfuric acid precipitation, and chemical recovery steps. These are not characteristics of a “minimally processed, plant-based” ingredient.
• The complaint uses this USDA finding to argue the ingredient meets the federal definition of “synthetic” under 7 C.F.R. § 205.2.

“[Citric acid] is a natural[ly] occurring substance that commercially goes through numerous chemical processes to get to [its] final usable form. This processing would suggest that it be classified as synthetic.”

— USDA AMS reviewers, cited in the complaint (Exhibit A at page 5).

• This is a direct government assessment, not a plaintiff’s characterization. Federal reviewers concluded that the extent of processing pushes commercial citric acid into the “synthetic” classification.
• In response to whether the substance is “Natural or Synthetic,” those same USDA AMS reviewers stated: “synthetic.” That single-word answer appears in the complaint as Exhibit A at pages 4-5.

“Marketers, nevertheless, are responsible for substantiating consumers’ reasonable understanding of ‘biobased,’ and other similar claims, such as ‘plant-based,’ in the context of its advertisements.”

— FTC Green Guides, 16 C.F.R. § 260, cited in the complaint.

• This is the FTC’s own published standard. It places the burden of verification on the company making the claim, not on the consumer trying to decode it.
• The complaint argues Dapple Baby disregarded this standard by formulating products with ingredients that are neither water nor plant, and in some cases entirely synthetic.

“Solvent extraction process for citric acid … recovery of citric acid from conventional Aspergillus niger fermentation liquor … (a) The solvent used in the process consists of a mixture of n-octyl alcohol … synthetic isoparaffinic petroleum hydrocarbons … and tridodecyl amine.”

— FDA regulation, 21 C.F.R. § 173.280, cited in the complaint.

• This is the FDA’s own description of the food-grade citric acid extraction process. It involves petroleum-derived solvents. The complaint notes these solvents “may be used to extract the citric acid in the Products and may leave potential residues.”
• The FDA has also issued warning letters to other companies, including Hirzel Canning Company and Oak Tree Farm Dairy, Inc., signaling regulatory concern about “natural” claims on products containing citric acid manufactured through this process.

Public Deception: The Label vs. The Lab

Dapple Baby built a brand identity around four claims printed on the front of its products. The complaint documents each claim and what the ingredient list actually shows.

• “Powered by Plants”: The products contain benzisothiazolinone (a synthetic preservative), polysorbate 20 (synthesized from sorbitol and polyol reacted with ethylene oxide), ethylhexylglycerin (a synthetic skin-softening agent), sodium percarbonate (an industrially manufactured bleaching agent with no plant origin), and manufactured citric acid produced through black mold fermentation and petroleum solvent extraction.
• “No Harsh Chemicals”: Two ingredients present in the products, benzisothiazolinone and ethylhexylglycerin, are documented skin allergens in peer-reviewed literature. Sodium benzoate has been shown in published research to cause DNA damage and chromosomal aberrations. The EPA classifies benzisothiazolinone as a moderate skin sensitizer.
• “Hypoallergenic”: The complaint identifies benzisothiazolinone, sodium benzoate, and ethylhexylglycerin as known allergens or skin irritants. Benzisothiazolinone is banned from personal care products across the EU specifically because of its allergen profile. Sodium benzoate is a recognized cause of urticaria and allergic contact dermatitis.
• “Baby Friendly”: The products are sold as safe for newborns and infants. The complaint notes that a 2012 Journal of Pediatrics article documented FDA warnings linking xanthan gum products to illness and death in infants. Xanthan gum is listed as an ingredient in Dapple Baby’s products. No warning or qualification appears on the label.
• Green-leaf imagery and botanical branding: The packaging surrounds the “powered by plants” and “Baby Friendly” claims with green-leaf graphics. The complaint identifies this as intentional use of botanical aesthetics to reinforce the impression of a nature-derived product, a perception contradicted by the product’s actual formulation.
• No asterisks, no percentages, no disclosures: The complaint specifically notes that Dapple Baby does not qualify any of its front-label plant-based claims with asterisks, percentage disclosures, or ingredient-level clarifications. There is no “made with plant-derived ingredients” caveat. The unqualified claim is left to speak for itself.

Profit-Maximization at All Costs

The complaint does not mince words about why synthetic ingredients end up in a product branded as natural: it is cheaper.

• Lower manufacturing costs, premium pricing: Paragraph 55 of the complaint states directly that “by using these ingredients, Defendant can reduce manufacturing costs while charging a premium for Products positioned as clean, plant-based alternatives.” This is the core financial mechanic. Substitute cheap synthetic inputs, charge more for the “natural” label.
• Manufactured citric acid instead of natural extraction: The complaint documents that naturally extracted citric acid from citrus fruits is “no longer commercially available” at scale, per USDA AMS reports. The industrial alternative, manufactured through black mold fermentation and sulfuric acid processing, is cheaper to produce. Dapple Baby uses the industrial version while the label implies the natural one.
• Synthetic preservatives over plant-derived alternatives: Benzisothiazolinone, sodium benzoate, and potassium sorbate are synthetic preservatives included in the products. The complaint notes these are “not derived from plants.” Their presence helps extend shelf life and reduce formulation costs while the plant-based label commands a price premium from parents seeking natural options.
• The “clean” and “natural” baby products market: The complaint notes this market “has grown significantly,” with companies including Dapple Baby scrambling to capture market share by positioning products as plant-based. The financial incentive to slap a plant-based label on a synthetic product is substantial: parents in this demographic are documented to pay more for perceived natural safety.
• No qualifying disclosures: Dapple Baby does not include asterisks, percentage breakdowns, or ingredient-level clarifications on any of its front-label claims. This omission is not accidental. Qualifying language reduces the perceived premium. The complaint identifies this as a deliberate choice to maximize the marketing effect of the “powered by plants” claim.

Societal Impact Mapping

Public Health

The health risks documented in the complaint are specific and sourced. These are not theoretical concerns about vague chemical exposure.

• Benzisothiazolinone is classified by the U.S. EPA as a moderate skin sensitizer. It is banned from personal care products in Europe. It is present in products marketed as “hypoallergenic” for use around infants.
• Sodium benzoate is documented in peer-reviewed research cited in the complaint (Zengin et al., Food and Chemical Toxicology, 2011) to cause DNA damage and chromosomal aberrations. It is also a recognized contact allergen known to cause skin irritation, urticaria, and allergic contact dermatitis.
• Ethylhexylglycerin is classified in peer-reviewed literature as a skin allergen and is associated with allergic contact dermatitis. It is present in products labeled hypoallergenic.
• Xanthan gum is present in the product line. A 2012 article in the Journal of Pediatrics noted FDA warnings that products containing xanthan gum have been linked to illness and death in infants. Dapple Baby’s products are marketed specifically to parents of newborns and infants.
• The FDA’s solvent extraction process for citric acid, described in 21 C.F.R. § 173.280 and cited in the complaint, involves petroleum-derived solvents including synthetic isoparaffinic petroleum hydrocarbons. The complaint states these solvents “may leave potential residues” in the finished product.

Economic Inequality

The harm documented here lands hardest on the parents who are most careful about what they buy, and who paid extra because they thought they were getting something safer.

• Parents seeking natural products for newborns represent a defined premium market. The complaint documents that Dapple Baby targets this demographic specifically, charging prices consistent with a natural, plant-based product while delivering synthetic formulations.
• The class action covers purchases made at mass-market retailers including Target, Walmart, and Amazon, meaning this is a product accessible to broad income levels, not a luxury niche. The premium extracted was taken from ordinary household budgets, not discretionary luxury spending.
• The complaint alleges that plaintiff Makayla McCanless made at least four separate purchases of Dapple Baby products between December 2024 and July 2025, each time relying on the plant-based representations. The financial injury is not a one-time event; it repeats with each purchase cycle.
• Families that cannot easily afford premium products often make deliberate sacrifices to buy what they believe is safer for their children. Greenwashing extracts that sacrifice under false pretenses.

What’s at Stake: The Numbers

No settlement has been reached. The case was filed April 1, 2026. The complaint establishes the financial architecture of the alleged harm.

• The complaint seeks five separate categories of relief: compensatory damages, restitution and disgorgement, punitive damages, attorneys’ fees, and injunctive relief requiring Dapple Baby to stop using “powered by plants” and “Hypoallergenic” claims on products containing synthetic ingredients.
• Plaintiff’s counsel sent a formal notice letter on November 24, 2025, giving Dapple Baby 30 days to cure its deceptive conduct on a class-wide basis. The company did not act. The lawsuit followed.
• The measure of damages proposed in the complaint is the price premium: the difference between what consumers paid for a product represented as natural and plant-based, and the actual market value of a product honestly labeled as containing synthetic industrial chemicals.

Inside the Bottle: Anatomy of a “Plant-Based” Product

What Dapple Baby presents as a unified plant-based product contains at least 12 ingredients the complaint identifies as synthetic, industrially manufactured, or federally classified as non-natural.